Progress in myocardial damage detection: New biochemical markers for clinicians

Critical Reviews in Clinical Laboratory Sciences

Volumn 34, Issue 1, 1997, Pages 1-66

  Mair, Johannes ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Annexin; Carbonic anhydrase; Creatine kinase; Diagnosis; Enolase; Fatty acid binding protein; Glycogen phosphorylase; Isoforms; Lactate dehydrogenase; Mass; Myocardial infarction; Myocardial injury; Myoglobin; Myosin heavy chains; Myosin light chains; Phosphoglyceric acid mutase; S100a0; Troponin I; Troponin T

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE; LACTATE DEHYDROGENASE; LIPOCORTIN 5; MYOGLOBIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; HEART MUSCLE INJURY; KIDNEY FAILURE; MYOPATHY; PRIORITY JOURNAL; REVIEW; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 0030936680     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.3109/10408369709038215     Document Type: Review

References (174)

1. Rude FE, Poole WK, Muller JE, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3697 patients. Am J Cardiol 1983; 52:936-42.
2. Graff L, Joseph T, Andelman R, et al. American college of emergency physicians information paper: chest pain units in emergency departments - a report from the short-term observation services section. Am J Cardiol 1995; 76:1036-9.
3. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. (WHO MONICA Project). Myocardial infarction and coronary death in the World Health Organization MONICA Project - registration procedures, event rates, and case fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994; 90:583-611.
4. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Annu Rev Med 1991; 42:225-46.
5. Di Lisa F, De Tullio R, Salamino F, et al. Specific degradation of troponin T and I by μ-calpain and its modulation by substrate phosphorylation. Biochem J 1995; 308:57-61.
6. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 1995; 9:219-28.
7. Gebhard MM, Denkhaus H, Sakai K, et al. Energy metabolism and enzyme release. J Mol Med 1977; 2:271-83.
8. Piper HM, Schwartz P, Spahr R, et al. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol 1984; 16:385-8.
9. Wienen W, Kammermeier H. Intra- and extracellular markers in interstitial transudate of perfused rat hearts. Am J Physiol 1988; 254:H785-94.
10. Heyndrickx GR, Amano J, Kenna T, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 1985; 6:1299-1305.
11. Michael LH, Hunt JR Weilbach D. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am J Physiol 1985; 248:350-9.
12. Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27:793-803.
13. Spiekermann PG, Nordbeck H Preusse CJ. From heart to plasma. In: Hearse DJ, De Leiris J, eds. Enzymes in cardiology: diagnosis and research. Pp 59-79, New York: John Wiley, 1979.
14. Van Kreel B, Van der Veen FH, Willems GM, et al. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264:H747-54.
15. Asayama J, Yamahara Y, Ohta B, et al. Release kinetics of cardiac troponin T in coronary effluent from isolated rat hearts during hypoxia and reoxygenation. Basic Res Cardiol 1992; 87:428-36.
16. Vorderwinkler KP, Mair J, Puschendorf B, et al. Cardiac troponin I increases in parallel to cardiac troponin T, creatine kinase and lactate dehydrogenase in effluents from isolated perfused rat hearts after hypoxia-reoxygenation-induced myocardial injury. Clin Chim Acta 1996; 251:113-7.
17. Vork MM, Glatz JF, Surtel DA, et al. Release of fatty acid binding protein and lactate dehydrogenase from isolated rat heart during normoxia, low-flow ischemia, and reperfusion. Can J Physiol Pharmacol 1993; 71:952-8.
18. Sunnergreen KP, Rovetto MJ. MIcrovascular permeability characteristics of isolated perfused ischemic rat heart. J Mol Cell Cardiol 1980; 12:1011-31.
19. Dauber IM, VanBenthuysen KM, McMurty IF, et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 1990; 66:986-98.
20. Mair J, Thome-Kromer B, Wagner I, et al. Concentration time courses of troponin and myosin subunits after acute myocardial infarction. Coronary Artery Dis 1994; 5:865-72.
21. Ladue JS, Wroblewski F Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction. Science 1954; 120:497-9.
22. Lee Th, Goldmann L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Intern Med 1986; 105:221-33.
23. Adams JE III, Abendschein DR Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88:750-63.
24. Mair J, Puschendorf B Michel G. Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury. Adv Clin Chem 1994; 31:63-98.
25. Werner M, Brooks SH, Mohrbacher RJ, et al. Diagnostic performance of enzymes in the discrimination of myocardial infarction. Clin Chem 1982; 28:1297-1302.
26. van Kreel BK, van der Veen FH, Willems GM, et al. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264:H747-54.
27. van der Laarse A, Hermens WT, Hollaar L, et al. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J 1984; 107:248-60.
28. van der Laarse A, Kerkhof PLM, Verneer F, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol 1988; 61:1-7.
29. Lee KN, Csako G, Bernhardt P, et al. Relevance of macro creatine kinase type 1 and 2 isoenzymes to laboratory and clinical data. Clin Chem 1994; 40:1278-83.
30. Neumaier D. Tissue specific distribution of creatine kinase isoenzymes. In: Lang H, ed. Creatine kinase isoenzymes - pathophysiology and clinical application. Pp 31-83. Berlin: Springer-Verlag, 1981.
31. Ingwall JS, Kramer MF, Fifer MA, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313:1050-4.
32. Apple FS, Rogers MA, Shermann WM, et al. Profile of creatine kinase isoenzymes in skeletal muscle of marathon runners. Clin Chem 1984; 30:413-6.
33. Somer H, Duboeitz V Donner M. Creatine kinase isoenzymes in neuromuscular diseases. J Neural Sci 1976; 29:129-36.
34. Chan KM, Ladenson JH, Pierce GF, et al. Increased creatine kinase MB in the absence of acute myocardial infarction. Clin Chem 1986; 32:2044-51.
35. Mair J, Artner-Dworzak E, Dienstl A, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991; 68:1545-50.
36. Mair J, Morandell D, Genser N, et al. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995; 41:1266-72.
37. Gibier WB, Runyon JP, Levy RC, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995; 25:1-8.
38. Laperche T, Steg PG, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. Circulation 1995; 92:2079-86.
39. Ravkilde J, Nissen H, Horder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected myocardial infarction. J Am Coll Cardiol 1995; 25:574-81.
40. Puleo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990; 82:759-64.
41. Kanemitsu F, Okigaki T. A combination assay of MB and MM isoforms of serum creatine kinase in acute myocardial infarction. Clin Chim Acta 1994; 229:161-9.
42. Bhayana V, Cohoe S, Leung FY, et al. Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. Clin Chem 1993; 39:488-95.
43. Erdös EG, Skidgel RA. More on subforms of creatine kinase MB (letter). N Engl J Med 1995; 333:390.
44. Wu JT, Pieper RK, Wu LH, et al. Isolation and characterization of myoglobin and its two major isoforms from sheep heart. Clin Chem 1989; 35:778-782.
45. Stone MJ, Willerson JT, Gomez-Sanchez CE, et al. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. J Clin Invest 1975; 56:1334-9.
46. Delanghe J, Chapelle JP Vanderschueren S. Quantitative nephelometric assay for determining myoglobin evaluated. Clin Chem 1990; 36:1675-8.
47. Mair J, Artner-Dworzak E, Lechleitner P, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68:462-8.
48. de Winter RJ, Koster RW, Sturk A, et al. Value of myoglobin, troponin T, and CKMB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92:3401-8.
49. Klocke FJ, Copley DP, Krawczyk JA, et al. Rapid renal clearance of immunoreactive canine plasma myoglobin. Circulation 1982; 65:1522-8.
50. Honda Y, Katayama T. Detection of myocardial infarction extension or reattack by serum myoglobin radioimmunoassay. Int J Cardiol 1984; 6:325-35.
51. Mair P, Mair J, Seibt I, et al. Early and rapid diagnosis of perioperative myocardial infarction in aortocoronary bypass surgery by immunoturbidimetric myoglobin measurements. Chest 1993; 103:1508-11.
52. Cooke R. The actomyosin engine. FASEB J 1995; 9:636-42.
53. Farah CS, Reinach FC. The troponin complex and regulation of muscle contraction. FASEB J 1995; 9:755-67.
54. Raggi A, Grand RJA, Moir AJG, et al. Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 1989; 997:135-43.
55. Pharmacek MS, Leiden JM. Structure, function and regulation of troponin C. Circulation 1991; 84:991-1003.
56. Yamauchi-Takihara K, Sole MJ, Liew J, et al. Characterization of human cardiac myosin heavy chain genes. Proc Natl Acad Sci USA 1989; 86:3504-8.
57. Barton PJR, Cohen A, Robert B, et al. The myosin alkali light chains of mouse ventricular and slow skeletal muscle are indistinguishable and are encoded by the same gene. J Biol Chem 1984; 260:8578-84.
58. Collins JH, Theibert JL Libera LD. Amino acid sequence of rabbit ventricular myosin light chain-2: identity with slow skeletal muscle isoform. Biosci Rep 1986; 6:655-71.
59. Schwartz K, Boheler KR, de la Bastie D, et al. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992; 262:R364-9.
60. Cummins P. The homology of the alpha chains of cardiac and skeletal rabbit tropomyosin. J Mol Cell Cardiol 1979; 11:109-14.
61. Pearlstone J, Carpenter M Smillie L. Amino acid sequences of rabbit cardiac troponin T. J Biol Chem 1986; 261:16795-810.
62. Wilkinson JM, Grand RJA. Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978; 271:31-5.
63. Anderson PAW, Malouf NN, Oakeley AE, et al. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 1991; 69:1226-33.
64. Katus HA, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 38:386-93.
65. Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67:1360-7.
66. Kragten JA, Hermens WT Dieijen-Visser MP. Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes. Ann Clin Biochem 1996; 33:314-23.
67. Saggin L, Gorza L, Ausoni S, et al. Cardiac troponin T in developing, regenerating and denerved rat skeletal muscle. Development 1990; 110:547-54.
68. Bodor G, Porterfield D, Voss E, et al. Cardiac troponin T composition in regenerating human skeletal muscle tissue (Abstr.). Clin Chem 1995; 41:148.
69. Mair J, Artner-Dworzak E, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37:845-52.
70. Katus HA, Remppis A, Neumann FL, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83:902-12.
71. Westfall MV, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 1990; 70:302-13.
72. Wagner I, Mair J, Fridrich L, et al. Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coronary Artery Dis 1993; 4:537-44.
73. Omura T, Teragaki M, Tani T, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J 1993; 57:1062-70.
74. Lee TH, Thomas EJ, Ludwig LE, et al. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol 1996; 77:1031-6.
75. Mair P, Mair J, Seibt I, et al. Cardiac troponin T: a new marker of myocardial tissue damage in bypass surgery. J Cardiothorac Vasc Anesth 1993; 7:674-8.
76. Hake U, Schmid FX, Iversen S, et al. Troponin T - a reliable marker of perioperative myocardial infarction. Eur J Cardiothorac Surg 1993; 7:628-33.
77. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327:146-50.
78. Lindahl B, Venge P, Wallentin L, et al. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93:1651-7.
79. Genser N, Mair J, Friedrich G, et al. Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentrations (letter). Am J Cardiol 1996; 78:127-8.
80. Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CKMB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127:13-20.
81. Bachmaier K, Mair J, Offner F, et al. Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis. Circulation 1995; 92:1927-32.
82. Franz WM, Remppis A, Kandolf R, et al. Serum troponin T: diagnostic marker for acute myocarditis (letter). Clin Chem 1996; 42:340-1.
83. Walpoth BH, Tschopp A, Perheim E, et al. Assessment of troponin T for detection of cardiac rejection in a rat model. Transplant Proc 1995; 27:2084-7.
84. Zimmermann R, Baki S, Dengler TJ, et al. Troponin T release after heart transplantation. Br Heart J 1993; 69:395-8.
85. Riou B, Dreux S, Roche S, et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 1995; 92:409-14.
86. Mair P, Mair J, Koller J, et al. Cardiac troponin T release in multiple injured patients. Injury 1995; 26:439-43.
87. Katus HA, Müller-Bardorff M, Hallermayer K, et al. The second generation of the cardiac troponin T ELISA: improved specificity (Abstr.). Clin Chem 1995; 41:S79.
88. Kobayashi S, Tanaka M, Tamura N, et al. Serum cardiac troponin T in polymyositis/dermatomyositis (letter). Lancet 1992; 340:726.
89. Thome-Kromer B, Michel G. Human cardiac troponin I - detectability after myocardial infarction and severe skeletal muscle damage (Abstr.). Clin Chem 1993; 39:1248.
90. Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure (letter). Clin Chem 1994; 40:1790-1.
91. Collinson PO, Stubbs PJ Rosalki SB. Cardiac troponin T in renal disease (letter). Clin Chem 1995; 41:1671-3.
92. Vallins WJ, Brand NJ, Dabjade N, et al. Molecular cloning of human troponin I using polymerase chain reaction. FEBS Lett 1990; 270:57-61.
93. Saggin L, Gorza L, Ausoni S, et al. Troponin I switching in the developing heart. J Biol Chem 1989; 264:16299-302.
94. Bhavsar P, Dhoot GK, Cumming DVE, et al. Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett 1991; 292:5-8.
95. Cummins B, Auckland ML Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113:1333-44.
96. Bodor GS, Porterfield D, Voss EM, et al. Cardiac troponin I is not expressed in fetal and healthy and diseased adult human skeletal muscle tissue. Clin Chem 1995; 41:1710-5.
97. Adams JE III, Schechtman KB, Landt Y, et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40:1291-5.
98. Mair J, Genser N, Morandell D, et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 1996; 245:19-38.
99. Larue C, Calzolari C, Bertinchant JP, et al. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39:972-9.
100. Apple FS, Henry TD, Berger CR, et al. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996; 105:6-10.
101. Mair J, Wagner I, Morass B, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 1995; 33:869-72.
102. Wu AHB, Feng YI Contois JH. Prognostic value of cardiac troponin I in chest pain patients (letter). Clin Chem 1996; 42:651-2.
103. Hunt AC, Chow SL, Shiu MF, et al. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J 1991; 12:690-4.
104. Adams JE III, Sicard GA, Allen BT, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670-4.
105. Mair J, Larue C, Mair P, et al. Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting. Clin Chem 1994; 40:2066-70.
106. Smith SC, Ladenson JH, Mason JW, et al. Detection of myocarditis by cardiac troponin I (Abstr.). Circulation 1994; 90 (Suppl. I.):547.
107. Grant JW, Canter CE, Spray TL, et al. Elevated donor cardiac troponin I - a marker of acute graft failure in infant heart recipients. Circulation 1994; 90:2618-21.
108. Adams JE III, Davila-Roman VG, Bossey PQ, et al. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 1996; 131:308-12.
109. Adams JE III, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I - a marker with high specificity for cardiac injury. Circulation 1993; 88:101-6.
110. Trinquier S, Flecheux O, Bullenger M, et al. Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma (letter). Clin Chem 1995; 41:1676.
111. Khaw BA, Gold HK, Fallon JT, et al. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains. Circulation 1978; 58:1130-6.
112. Gere JB, Krauth GH, Trahern CA, et al. A radioimmunoassay for the measurement of human cardiac light chains. Am J Clin Pathol 1979; 71:309-18.
113. Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Pp 114-8. Heidelberg: Springer, 1996.
114. Mair J, Wagner I, Jakob G, et al. Different time courses of cardiac contractile proteins after acute myocardial infarction. Clin Chim Acta 1994; 231:47-60.
115. Katus HA, Yasada T, Gold HK, et al. Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. Am J Cardiol 1984; 54:964-70.
116. Katus HA, Diederich KW, Schwarz F, et al. Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol 1987; 60:440-5.
117. Isobe M, Nagai R, Ueda S, et al. Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction. Circulation 1987; 76:1251-61.
118. Mair J, Wagner I, Fridrich L, et al. Cardiac myosin light chain-1 release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Clin Chim Acta 1994; 229:153-9.
119. Omura T, Teregaki M, Tagaki M, et al. Myocardial infarct size by serum troponin T and myosin light chain-1 concentration. Jpn Circ J 1995; 59:154-9.
120. Nakai K, Itoh C, Kikuchi M, et al. Increased serum levels of human cardiac myosin light chain 1 in patients with renal failure. Rinsho Byori 1992; 40:529-34.
121. Fukunaga H, Higuchi I, Usuki F, et al. Clinical significance of serum cardiac myosin light chain 1 in patients with Duchenne muscular dystrophy. No To Shinkei 1992; 44:131-5.
122. Diederich KW, Eisele I, Ried T, et al. Isolation and characterization of the complete human beta-myosin heavy chain gene. Hum Genet 1989; 81:214-20.
123. Bredman JJ, Wessels A, Weijs WA, et al. Demonstration of "cardiac-specific" myosin heavy chain in masticatory muscles of human and rabbit. Histochem J 1991; 23:160-70.
124. Larue C, Calzolari C, Leger J, et al. Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction. Clin Chem 1991; 37:78-82.
125. Simeonova PP, Kehayov IR Kyurkchiev SD. Identification of human ventricular myosin heavy chain fragments with monoclonal antibody 2F4 in human sera after myocardial necrosis. Clin Chim Acta 1991; 201:207-22.
126. Leger JOC, Larue C, Ming T, et al. Assay of serum cardiac myosin heavy chain fragments in patients with acute myocardial infarction: determination of infarct size and long-term follow-up. Am Heart J 1990; 120:781-90.
127. Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Pp 110-4. Heidelberg: Springer, 1996.
128. Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Pp 79-80. Heidelberg: Springer, 1996.
129. Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41:966-78.
130. Krause EG, Rabitzsch G, Noll F, et al. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction. Mol Cell Biochem 1996 (in press).
131. Krause EG, Härtwig A Rabitzsch G. On the release of glycogen phosphorylase from heart muscle: effect of substrate depletion, ischemia, and of imipramine. Biomed Biochim Acta 1989; 48:S77-S82.
132. Newgard CB, Hwang PK Fletterick RJ. The family of glycogenphosphorylases: structure and function. Crit Rev Biochem Mol Biol 1989; 24:69-99.
133. Mair J, Puschendorf B, Smidt J, et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J 1994; 72:125-7.
134. Mair P, Mair J, Krause E-G, et al. Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur J Clin Chem Clin Biochem 1994; 34:543-7.
135. Kleine AH, Glatz JFK, van Nieuwenhoven FA, et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116:155-62.
136. Glatz JFC, van der Vusse GJ. Cellular fatty acid-binding proteins: current concepts and future directions. Mol Cell Biochem 1990; 98:237-51.
137. Kragten JA, van Nieuwenhoven FA, van Dieijen-Visser MP, et al. Distribution of myoglobin and fatty acid binding protein in human heart (letter). Clin Chem 1996; 42:337-8.
138. Roos W, Eymann E, Symannek M, et al. Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods 1995; 183:149-53.
139. Ohkaru Y, Asayama K, Ishii H, et al. Developmental of a sandwich enzyme-linked immunosorbent assay for the determination of human heart-type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995; 178:99-111.
140. Watanabe K, Wakabayashi H, Veerkamp JH, et al. Immunohistochemical distribution of heart-type fatty acid binding protein immunoreactivity in normal human tissues and in acute myocardial infarct. J Pathol 1993; 170:59-65.
141. Van Nieuwenhoven FA, Kleine AH, Wodzig KWH, et al. Discrimination between myocardial and skeletal muscle injury by assessment of plasma ratio of myoglobin over fatty acid binding protein. Circulation 1995; 92:2848-54.
142. Glatz JFC, Kleine AH, van Nieuwenhoven FA, et al. Fatty-acid binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994; 71:135-40.
143. Tsuji R, Tanaka T, Sohmiya K, et al. Human heart-type cytoplasmic fatty acid binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993; 41:209-17.
144. Jeffery S, Carter N Edwards Y. Distribution of CA III in fetal and adult human tissue. Biochem Genet 1980; 18:843-9.
145. Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64:375-401.
146. Väänänen HK, Syrjälä H, Rahkila P, et al. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. Clin Chem 1990; 36:635-8.
147. Vuori J, Syrjälä H Väänänen HK. Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. Clin Chem 1996; 42:107-9.
148. 0 (αα) protein: distribution in muscle tissue of various animals and purification from human pectoral muscle. J Neurochem 1986; 46:1555-60.
149. 0 protein is mainly located in the heart and striated muscles. Biochim Biophys Acta 1985; 842:146-50.
150. 0 protein in serum during acute myocardial infarction. Clin Chem 1990; 36:639-41.
151. Usui A, Kato K, Abe T, et al. S-100 protein in blood and urine during open heart surgery. Clin Chem 1989; 35:1942-4.
152. Kaneko N, Matsuda R, Hosoda S, et al. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996; 251:65-80.
153. Kato K, Ishiguro Y Ariyoshi Y. Enolase isoenzymes as disease markers: distribution of three enolase subunits (α, β, and γ) in various human tissues. Dis Markers 1983; 1:213-20.
154. Nomura M, Kato K, Nagasaka A, et al. Serum β-enolase in acute myocardial infarction. Br Heart J 1987; 58:29-33.
155. Herraz-Dominguez M, Goldberg D, Anderson A, et al. Serum enolase and pyruvate kinase activities in the diagnosis of myocardial infarction. Enzyme 1976; 21:211-24.
156. Usui A, Kato K, Abe T, et al. β-Enolase in blood plasma during open heart surgery. Cardiovasc Res 1989; 23:737-40.
157. Uchida K, Kondoh K Matuo Y. Recombinant M-, B-, and MB-type isozymes of human phosphoglyceric acid mutase: their large-scale production and preparation of polyclonal antibodies specific to M- and B-type isozymes. Clin Chim Acta 1995; 237:43-58.
158. Omenn GS, Cheung SCY. Phosphoglycerate mutase isozyme marker for tissue differentiation in man. Am J Hum Genet 1974; 26:393-9.
159. Stewart RE, O'Neill WW. Direct angioplasty for acute myocardial infarction. Curr Opin Cardiol 1995; 10:367-71.
160. Madias JE. Acute myocardial infarction: shifting paradigms of diagnosis and care in cost-conscous environment. Chest 1995; 108:1483-5.
161. Zabel M, Hohnloser SH, Köster W, et al. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993; 87:1542-50.
162. Grover A, Rihal CS. The importance of early patency after acute myocardial infarction. Curr Opin Cardiol 1995; 10:361-6.
163. Doevendans PA, Gorgels AP, van der Zee R, et al. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995; 75:1206-10.
164. McKendall GR, Forman S, Sopko G, et al. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995; 76:1108-11.
165. Aguirre FV, Merritt RF Carollo SC. The role of coronary angiography after thrombolysis. Curr Opin Cardiol 1995; 10:381-8.
166. Mair J, Smidt J, Lechleitner P, et al. A decision tree for the early diagnosis of acute myocardial infarction in non-traumatic chest pain patients at hospital admission. Chest 1995; 108:1502-9.
167. Bakker AJ, Koelemay MJW, Gorgels JPMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342:1220-2.
168. Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set". Circulation 1994; 89:872-81.
169. Ohman EM, Armstrong P, Califf RM, et al. Risk stratification in acute ischaemic syndromes using serum troponin T. J Am Coll Cardiol 1995; 25:148A.
170. Betriu A, Heras M, Cohen M, et al. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992; 19:1659-63.
171. Rizik DG, Healy S, Margulis A, et al. A new clinical classification for hospital prognosis of unstable angina pectoris. Am J Cardiol 1995; 75:993-7.
172. Feghali NT, Prisant ML. Blunt cardiac injury. Chest 1995; 108:1673-7.
173. Katus HA. Ischaemic myocardial damage early detection: biochemical markers. Oral communication. Eur Soc Cardiol Symp Sophia Antipolis, France, February 1996.
174. Mair J. Unpublished results.